Syneron Medical to Participate in Three Investor Conferences in November

13 Nov, 2015, 10:10 ET from Syneron Medical Ltd.

IRVINE, Calif., Nov. 13, 2015 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that management is scheduled to participate in three investor conferences in November 2015. The first conference is the Brean Capital 2015 Life Sciences Summit in New York City. This conference will allow institutional investors to meet with the Company but does not include a formal presentation.

Conference:

Brean Capital 2015 Life Sciences Summit

Date:

Monday November 16, 2015

The second conference is the Barclays MedTech SMID Cap Day in New York City. This conference will allow institutional investors to meet with the Company but does not include a formal presentation.

Conference:

Barclays MedTech SMID Cap Day

Date:

Monday November 16, 2015

The third conference is the Stifel 2015 Healthcare Conference in New York City. This conference includes a formal presentation.

Conference:

Stifel 2015 Healthcare Conference

Date:

Tuesday, November 17, 2015

Time:

8:00 am ET

The Stifel conference presentation will be webcast live over the Internet and can be accessed through the Investor Relations section on Syneron's website at www.investors.syneron.com. Please go to the website a few minutes early, as it may be necessary to download audio software to hear the presentations.

About Syneron Candela: Syneron Candela is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, tattoo removal, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under three distinct brands, Syneron, Candela and CoolTouch, and has a wide portfolio of trusted, leading products including UltraShape, VelaShape, GentleLase, VBeam Perfecta, PicoWay, Profound and elos Plus.

Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Candela are located in Israel. Syneron Candela also has R&D and manufacturing operations in the U.S. The company markets, services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia,China, Japan, and Hong Kong and distributors worldwide.

For additional information, please visit http://www.syneron-candela.com.

Logo - http://photos.prnewswire.com/prnh/20120528/535447

SOURCE Syneron Medical Ltd.



RELATED LINKS

http://www.syneron-candela.com